Full Text View
Tabular View
No Study Results Posted
Related Studies
Comparison of Voriconazole and Amphotericin B in Treating Patients With Aspergillosis
This study is ongoing, but not recruiting participants.
Study NCT00003031   Information provided by National Cancer Institute (NCI)
First Received: November 1, 1999   Last Updated: May 9, 2009   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Infection
Pulmonary Complications
Additional conditions recognized in this trial
Aspergillosis
Communicable Diseases
More general conditions related to this trial
Mycoses
Interventions listed in this trial
amphotericin B deoxycholate
voriconazole
Additional drug interventions recognized in this trial
Abelcet
Amphotericin B
Amphotericin B-deoxycholate
Deoxycholic Acid
Liposomal amphotericin B
More general drug interventions related to this trial
Amebicides
Anti-Bacterial Agents
Anti-Infective Agents
Antibiotics, Antifungal
Antifungal Agents
Antiparasitic Agents
Antiprotozoal Agents
Cholagogues and Choleretics
Gastrointestinal Agents
Pharmacologic Actions
Therapeutic Uses
Sponsors listed in this trial
European Organization for Research and Treatment of Cancer


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services